Search by Drug Name or NDC

NDC 00115-1725-03 Ultramicrosize Griseofulvin 250 mg/1 Details

Ultramicrosize Griseofulvin 250 mg/1

Ultramicrosize Griseofulvin is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is GRISEOFULVIN.

MedlinePlus Drug Summary

Griseofulvin is used to treat skin infections such as jock itch, athlete's foot, and ringworm; and fungal infections of the scalp, fingernails, and toenails. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Related Packages: 00115-1725-03
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Griseofulvin

Product Information

NDC	00115-1725
Product ID	0115-1725_4b54c9f5-4d73-4578-aa08-6d457c8cb664
Associated GPIs	11000030200315
GCN Sequence Number	009522
GCN Sequence Number Description	griseofulvin ultramicrosize TABLET 250 MG ORAL
HIC3	W3A
HIC3 Description	ANTIFUNGAL ANTIBIOTICS
GCN	42412
HICL Sequence Number	004127
HICL Sequence Number Description	GRISEOFULVIN ULTRAMICROSIZE
Brand/Generic	Generic
Proprietary Name	Ultramicrosize Griseofulvin
Proprietary Name Suffix	n/a
Non-Proprietary Name	Ultramicrosize Griseofulvin Tablets
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, COATED
Route	ORAL
Active Ingredient Strength	250
Active Ingredient Units	mg/1
Substance Name	GRISEOFULVIN
Labeler Name	Amneal Pharmaceuticals of New York LLC
Pharmaceutical Class	Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA204371
Listing Certified Through	2024-12-31

Package

NDC 00115-1725-03 (00115172503)

Pricing Information	N/A
NDC Package Code	0115-1725-03
Billing NDC	00115172503
Package	1000 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1725-03)
Marketing Start Date	2014-09-29
NDC Exclude Flag	N